What is Mitiglinide calcium?

Mitiglinide calcium is a biologic for the analysis of blazon 2 diabetes. It is a awful careful KATP approach adversary Mitiglinide calcium is a hypoglycemic abettor that closes adenosine triphosphate (ATP)–sensitive potassium channels (KATP approach s) in the pancreatic β-islet cells.
Mitiglinide calcium belongs to the meglitinide chic of claret glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to Mitiglinide calcium are captivated by Elixir Pharmaceuticals. Mitiglinide calcium has not yet acquired FDA approval.